The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
 
Emre Yekeduz
No Relationships to Disclose
 
Ismail Erturk
No Relationships to Disclose
 
Deniz Tural
No Relationships to Disclose
 
Nuri Karadurmus
No Relationships to Disclose
 
Serdar Karakaya
No Relationships to Disclose
 
Mutlu Hizal
No Relationships to Disclose
 
Çağatay Arslan
No Relationships to Disclose
 
Hakan Taban
No Relationships to Disclose
 
Ahmet Küçükarda
No Relationships to Disclose
 
Nihan Şentürk Öztaş
No Relationships to Disclose
 
Ozlem Nuray Sever
No Relationships to Disclose
 
Gokhan Uçar
No Relationships to Disclose
 
Mehmet Ali Nahit Sendur
No Relationships to Disclose
 
Umut Demirci
No Relationships to Disclose
 
Saadettin Kilickap
Consulting or Advisory Role - MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Speakers' Bureau - MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
 
Irfan Cicin
Consulting or Advisory Role - Abbvie (Inst); Abdi Ibrahim (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Nobelpharma (Inst); Novartis/Ipsen (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst); Teva
Speakers' Bureau - Abdi Ibrahim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Berna Oksuzoglu
No Relationships to Disclose
 
Mustafa Ozguroglu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Yuksel Urun
No Relationships to Disclose